Literature DB >> 31305304

Inflammasomes Assemble: Cytoplasmic Guardians or Fallen Heroes?

Pratik Sinha1, Carolyn S Calfee.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31305304      PMCID： PMC7043370          DOI： 10.1097/CCM.0000000000003872

Source DB:  PubMed          Journal:  Crit Care Med        ISSN： 0090-3493            Impact factor:   7.598


× No keyword cloud information.
  21 in total

1.  An absolute requirement for STAT4 and a role for IFN-gamma as an amplifying factor in IL-12 induction of the functional IL-18 receptor complex.

Authors:  M Nakahira; M Tomura; M Iwasaki; H J Ahn; Y Bian; T Hamaoka; T Ohta; M Kurimoto; H Fujiwara
Journal:  J Immunol       Date:  2001-08-01       Impact factor: 5.422

2.  Proteinase 3 expression on neutrophil membranes from patients with infectious disease.

Authors:  Takeshi Matsumoto; Toshihiro Kaneko; Hideo Wada; Toshihiko Kobayashi; Yasunori Abe; Tsutomu Nobori; Hiroshi Shiku; Deborah J Stearns-Kurosawa; Shinichiro Kurosawa
Journal:  Shock       Date:  2006-08       Impact factor: 3.454

3.  Activation of NLRP3 inflammasome in alveolar macrophages contributes to mechanical stretch-induced lung inflammation and injury.

Authors:  Jianbo Wu; Zhibo Yan; David E Schwartz; Jingui Yu; Asrar B Malik; Guochang Hu
Journal:  J Immunol       Date:  2013-02-22       Impact factor: 5.422

4.  Statins and pulmonary fibrosis: the potential role of NLRP3 inflammasome activation.

Authors:  Jin-Fu Xu; George R Washko; Kiichi Nakahira; Hiroto Hatabu; Avignat S Patel; Isis E Fernandez; Mizuki Nishino; Yuka Okajima; Tsuneo Yamashiro; James C Ross; Raúl San José Estépar; Alejandro A Diaz; Hui-Ping Li; Jie-Ming Qu; Blanca E Himes; Carolyn E Come; Katherine D'Aco; Fernando J Martinez; MeiLan K Han; David A Lynch; James D Crapo; Danielle Morse; Stefan W Ryter; Edwin K Silverman; Ivan O Rosas; Augustine M K Choi; Gary M Hunninghake
Journal:  Am J Respir Crit Care Med       Date:  2012-01-12       Impact factor: 21.405

5.  Cutting edge: FAS (CD95) mediates noncanonical IL-1β and IL-18 maturation via caspase-8 in an RIP3-independent manner.

Authors:  Lukas Bossaller; Ping-I Chiang; Christian Schmidt-Lauber; Sandhya Ganesan; William J Kaiser; Vijay A K Rathinam; Edward S Mocarski; Deepa Subramanian; Douglas R Green; Neal Silverman; Katherine A Fitzgerald; Ann Marshak-Rothstein; Eicke Latz
Journal:  J Immunol       Date:  2012-11-09       Impact factor: 5.422

6.  A novel IL-18BP ELISA shows elevated serum IL-18BP in sepsis and extensive decrease of free IL-18.

Authors:  D Novick; B Schwartsburd; R Pinkus; D Suissa; I Belzer; Z Sthoeger; W F Keane; Y Chvatchko; S H Kim; G Fantuzzi; C A Dinarello; M Rubinstein
Journal:  Cytokine       Date:  2001-06-21       Impact factor: 3.861

7.  Serum IL-18 and IL-18BP levels in patients with Chikungunya virus infection.

Authors:  Chintana Chirathaworn; Pornpimol Rianthavorn; Norra Wuttirattanakowit; Yong Poovorawan
Journal:  Viral Immunol       Date:  2010-02       Impact factor: 2.257

8.  Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomised controlled trial.

Authors:  Carolyn S Calfee; Kevin L Delucchi; Pratik Sinha; Michael A Matthay; Jonathan Hackett; Manu Shankar-Hari; Cliona McDowell; John G Laffey; Cecilia M O'Kane; Daniel F McAuley
Journal:  Lancet Respir Med       Date:  2018-08-02       Impact factor: 30.700

9.  Rosuvastatin for sepsis-associated acute respiratory distress syndrome.

Authors:  Jonathon D Truwit; Gordon R Bernard; Jay Steingrub; Michael A Matthay; Kathleen D Liu; Timothy E Albertson; Roy G Brower; Carl Shanholtz; Peter Rock; Ivor S Douglas; Bennett P deBoisblanc; Catherine L Hough; R Duncan Hite; B Taylor Thompson
Journal:  N Engl J Med       Date:  2014-05-18       Impact factor: 91.245

10.  Latent class analysis of ARDS subphenotypes: a secondary analysis of the statins for acutely injured lungs from sepsis (SAILS) study.

Authors:  Pratik Sinha; Kevin L Delucchi; B Taylor Thompson; Daniel F McAuley; Michael A Matthay; Carolyn S Calfee
Journal:  Intensive Care Med       Date:  2018-10-05       Impact factor: 17.440
View more
  1 in total

1.  Inhibition of Caspase-1 with Tetracycline Ameliorates Acute Lung Injury.

Authors:  Konrad Peukert; Mario Fox; Susanne Schulz; Caroline Feuerborn; Stilla Frede; Christian Putensen; Hermann Wrigge; Beate Mareike Kümmerer; Sascha David; Benjamin Seeliger; Tobias Welte; Eicke Latz; Dennis Klinman; Christoph Wilhelm; Folkert Steinhagen; Christian Bode
Journal:  Am J Respir Crit Care Med       Date:  2021-07-01       Impact factor: 21.405
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.